It is shown on theoretical grounds that, assuming tubocurarine elimination is an exponential process and the intensity of its pharmacological activity is proportional to the logarithm of the dose, the decline of activity is likely to be linear with time. This conclusion is supported by clinical data.
The design of rational dosage schedules of tubocurarine to obtain sustained muscular relaxation has recently been described by Ryan (1964) . His paper dealt primarily with the time course of tubocurarine concentration or amount in the body; it is intended here to consider the time course of tubocurarine activity.
Let it be assumed that the intensity of pharmacological activity of tubocurarine is related linearly to the logarithm of the body drug content (dose). This is a common finding with most drugs and applies over a considerable range of pharmacological activity. In mathematical terms I = ni \o%A + i (1) where / is the intensity of pharmacologic activity, A is the amount of tubocurarine in the body, m is the slope of the line when I is plotted against log A, and t is the intercept of the line on the / axis.
Assuming exponential disappearance of tubocurarine from the body,
where A is the amount of tubocurarine in the body at time t, A o is the intercept at zero time of the extrapolated linear portion of a plot of log A versus t, and K is the first-order elimination rate constant for tubocurarine.
Equations (1) and (2) may be combined (Levy, 1964) than exponentially) with time. This is indeed the case, as shown in figure 1 (based on data from Bellville, Cohen and Hamilton, 1964) , which depicts tubocurarine plasma concentration and degree of muscular relaxation (determined on the basis of decrease in grip strength) as a function of time. It is evident that drug concentration decreases exponentially, and activity decreases linearly (i.e., at a constant rate), with time. This is contrary to the frequently expressed assumption that the change of pharmacologic activity with time parallels that of drug concentration or body drug contents.
RAPPORT ENTRB LE RYTHME D'ELIMINA-TION DE LA TUBOCURARINE ET LA RAP1DITE DE DISPARITION DE SON ACTIVITE PHARMACOLOGIQUE

SOMMALRE
On montre par des arguments the'oriques qui si Ton admet que l'e'limination de la tubocurarine est un processus exponentiel et que l'intensit^ de son activity pharmacologique est proportionnelle au logarythme de la dose, la disparition de son activity est probablemnt en relation lineaire avec le temps. Cette conclusion est confirme'e par des donndes cliniques. In September 1966 an International Symposium will be organized to discuss interactions which may occur between the drugs employed in the preparation of patients for surgical operations and anaesthesia. (Drugs pertaining to pre-anaesthesia are excluded).
BEZIEHUNG ZWISCHEN DER AUSSCHEIDUNGS-RATE DES TUBOCURARINS UND DER RATE DES ABFALLES DER PHARMAKOLOGISCHEN WIRKSAMKETT
ZUSAMMENFASSUNG
The meeting will be based only on panel discussions (reports are not allowed) and will deal with the following subjects: Antibiotics; Hormones; Analgetics; Psychotropes; Cardiokinetics and diuretics; Cardiotonics and analeptics; Hypotensors and ganglioplegics; Vasoconstrictors; Hydrotherapy.
Simultaneous translations will be performed in French, English, Italian and German. A prospectus will be sent by the end of January 1965. For further information please apply to: Dr. Ruggero Rizzi, Ospedale Civile, Vicenza (Italy).
